Although pathogenic variants in the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) genes account for less than 1% of all AD cases, nearly all individuals carrying such mutations will eventually develop the disease. This evidence concerns the gene PSEN2 and Alzheimer disease.